Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
- B7872 5-MethoxytryptamineSummary: A complete agonist of 5-HT1, 5-HT2, 5-HT4, 5-HT6 and 5-HT7 receptors.
- C4910 SpermineSummary: Mixed NMDA glutamate receptor agonist/antagonist at the polyamine site
- C4947 N-(3-hydroxyphenyl)-Arachidonoyl amideSummary: selective, irreversible inhibitor of COX-2
- C5214 6-fluoro-DL-TryptophanSummary: serotonin (5-HT) synthesis inhibitor
- C5264 (S)-FlurbiprofenSummary: inhibitors of COX-1 and COX-2
- C5271 AL 34662Summary: potent 5-HT2 receptor agonist
- C5707 MyosmineSummary: agonist at neuronal nicotinic acetylcholine receptors
- C5314 cis-Flupenthixol (hydrochloride)Summary: antagonist at dopamine D2 receptors
- C5734 Trimipramine (maleate)Summary: potent antagonist of histamine H1 receptor
- C5515 Eicosatetraynoic AcidSummary: nonspecific inhibitor of cyclooxygenases and lipoxygenases